"Despite the fact that an association between semaglutide treatment and NAION was found, current evidence remains insufficient to establish definitive conclusions regarding its association with NAION," the report said
Retatrutide is a new, powerful weight loss medication developed by Eli Lilly that simultaneously activates three key receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors
doi:10.1016/S1262-3636(08)73397-4 12
PlexusDx helps patients optimize their GLP-1 injection schedules based on individual response patterns and lifestyle factors
Following red blood cell lysis (BioLegend), viability was determined by staining with Ghost dye (Tonbo Biosciences, Inc.) followed by FcR-blocking (Tonbo Biosciences, Inc.)
This is especially dangerous for users who assume cold weather means their medication is automatically safe